Cannabidiol ameliorates seizures and neuronal damage in ferric chloride-induced posttraumatic epilepsy by targeting TRPV1 channel., PMID:40449694
Effects of early access to feed and water in hatchers on growth performance in broiler chickens., PMID:40424958
Efficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial., PMID:40015292
High rate of RNAemia and impaired immunity in patients with immunodeficiency in the vaccination era., PMID:39985863
Long-term outcomes of passive immunotherapy for COVID-19: a pooled analysis of a large multinational platform randomized clinical trial., PMID:39922466
Semi-mechanistic population pharmacokinetic modeling of DZIF-10c, a neutralizing antibody against SARS-Cov-2: predicting systemic and lung exposure following inhaled and intravenous administration., PMID:39636474
The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastoma., PMID:39307412
Passive immunization of mice with IgY anti-H5N1 protects against experimental influenza virus infection and allows development of protective immunity., PMID:39019655
Lecanemab demonstrates highly selective binding to Aβ protofibrils isolated from Alzheimer's disease brains., PMID:38906341
Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study., PMID:38815595
Impaired malin expression and interaction with partner proteins in Lafora disease., PMID:38588813
Rituximab-combined anthracycline-free chemotherapy in newly diagnosed paediatric and adolescent patients with non-high-risk aggressive mature B cell lymphoma: protocol for a single-arm, open-label, multicentre, phase II study (the Japan Children's Cancer Group Multicentre Trial, JPLSG B-NHL-20)., PMID:38508620
Comparison of Infectious Complications with BCMA-directed Therapies in Multiple Myeloma., PMID:38405866
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19., PMID:38376212
Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial., PMID:38112205
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19., PMID:37948759
Single-agent belantamab mafodotin in patients with relapsed/refractory multiple myeloma: Final analysis of the DREAMM-2 trial., PMID:37622738
Humoral and cellular responses to repeated COVID-19 exposure in multiple sclerosis patients receiving B-cell depleting therapies: a single-center, one-year, prospective study., PMID:37449202
Development of Antiplasmodial Peptide-Drug Conjugates Using a Human Protein-Derived Cell-Penetrating Peptide with Selectivity for Infected Cells., PMID:37232456
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial., PMID:37227187
Cost-effectiveness analysis alongside the inter-B-NHL ritux 2010 trial: rituximab in children and adolescents with B cell non-Hodgkin's lymphoma., PMID:37058173
Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study., PMID:36949461
Primary Mediastinal B-Cell Lymphoma in Children and Young Adults., PMID:36898366
Immune response to mRNA-based COVID-19 booster vaccination in people living with HIV., PMID:36883641
Laforin targets malin to glycogen in Lafora progressive myoclonus epilepsy., PMID:36511140
Burkitt lymphoma after solid-organ transplant: Treatment and outcomes in the paediatric PTLD collaborative., PMID:36454546
[Recurrent SARS-CoV-2 infections in immunodeficiency]., PMID:36307654
Concordance of SARS-CoV-2 Antibody Results during a Period of Low Prevalence., PMID:36173112
NCF4 dependent intracellular reactive oxygen species regulate plasma cell formation., PMID:36095971
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19., PMID:36037469
Increased plasma and brain immunoglobulin A in Alzheimer's disease is lost in apolipoprotein E ε4 carriers., PMID:36008818
Strong T-cell activation in response to COVID-19 vaccination in multiple sclerosis patients receiving B-cell depleting therapies., PMID:35990701
SARS-CoV-2-neutralising monoclonal antibodies to prevent COVID-19., PMID:35713300
MicroRNA and interleukin 6 interplay in the adipose tissue of rheumatoid arthritis patients., PMID:35579086
Effect of 3BNC117 and romidepsin on the HIV-1 reservoir in people taking suppressive antiretroviral therapy (ROADMAP): a randomised, open-label, phase 2A trial., PMID:35544074
Recommendations for the Outpatient Drug Treatment of Patients With COVID-19., PMID:35506263
The Spectrum of B Cell Functions in Atherosclerotic Cardiovascular Disease., PMID:35497984
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience., PMID:35472167
Brain Perfusion Alterations on 3D Pseudocontinuous Arterial Spin-Labeling MR Imaging in Patients with Autoimmune Encephalitis: A Case Series and Literature Review., PMID:35393361
Rituximab in addition to LMB-based chemotherapy regimen in children and adolescents with primary mediastinal large B-cell lymphoma: results of the French LMB2001 prospective study., PMID:35236054
Coxsackie B virus., PMID:35183399
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial., PMID:35093205
SARS-CoV-2-neutralizing antibody treatment in patients with COVID-19 and immunodeficiency due to B-cell non-Hodgkin lymphoma., PMID:34911078
Clinical Practice Guideline: Recommendations on the In-hospital Treatment of Patients with COVID-19., PMID:34789365
ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease., PMID:34737044
[New MAA: First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma]., PMID:34654542
Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect., PMID:34497136
Pax5 regulates B cell immunity by promoting PI3K signaling via PTEN down-regulation., PMID:34301800
Antibodies to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in All of Us Research Program Participants, 2 January to 18 March 2020., PMID:34128970
For research use only. Not for human or drug use.
